Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 75 of 248 entries
View as:

Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06540950 Org: User:
Start: 03/20/23 End: 06/10/26 Due: 06/10/27

MRI Simulation-guided Boost in Short-course Preoperative Radiotherapy for Unresectable Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03714490 Org: User:
Start: 10/23/18 End: 09/30/25 Due: 09/30/26

Chemoradiotherapy in Esophageal or Esophagogastric Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04821778 Org: User:
Start: 01/01/02 End: 12/31/25 Due: 12/31/26

SHR-A1811 in Combination With Adebrelimab for the Treatment of HER2 Low-expressing Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06411457 Org: User:
Start: 05/16/24 End: 05/01/26 Due: 05/01/27

A Multi-omics Sequencing-based Model for Predicting Efficacy and Dynamic Monitoring of Treatment in Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT07026669 Org: User:
Start: 01/01/25 End: 12/01/27 Due: 12/01/28

To Evaluate the Efficacy and Safety of Anlotinib Combined With Furmonertinib Mesylate in Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04671303 Org: User:
Start: 01/01/21 End: 07/27/23 Due: 07/27/24

Study of Tislelizumab Plus Chemotherapy vs Chemotherapy as Perioperative Treatment in Participants With HER2 Negative Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04498793 Org: User:
Start: 09/30/20 End: 12/31/22 Due: 12/31/23

Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01024712 Org: User:
Start: 05/31/09 End: - Due: -

Real-world Clinical Outcomes of Patients With Early-stage Lung Cancer After the Surgery

Phase: N/A Priority: Normal
NCT ID: NCT06483698 Org: User:
Start: 03/01/24 End: 12/31/34 Due: 12/31/35

Deep Learning-based Classification and Prediction of Radiation Dermatitis in Head and Neck Patients

Phase: N/A Priority: Normal
NCT ID: NCT05607225 Org: User:
Start: 07/01/22 End: 06/30/25 Due: 06/30/26

Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06419673 Org: User:
Start: 05/01/24 End: 05/31/28 Due: 05/31/29

A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Performance Improvement From Computer-aided Tool for the Prognostic Prediction of Colorectal Liver Metastases

Phase: N/A Priority: Normal
NCT ID: NCT07027605 Org: User:
Start: 01/01/25 End: 05/25/25 Due: 05/25/26

Evaluate the Efficacy and Safety of Adebrelimab Combined With Chemotherapy With or Without Radiotherapy as Neoadjuvant Treatment for HER2-Negative Locally Advanced Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06908668 Org: User:
Start: 03/31/25 End: 09/10/28 Due: 09/10/29

MRD-Guided Consolidation Therapy Following Definitive Radiotherapy in Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06498752 Org: User:
Start: 07/16/24 End: 06/30/25 Due: 06/30/26

Perioperative Electroacupuncture for Gastric Cancer Patients After Gastrectomy

Phase: N/A Priority: Normal
NCT ID: NCT03291574 Org: User:
Start: 07/29/17 End: 12/31/20 Due: 12/31/21

Chemoradiotherapy in Unresectable Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04278287 Org: User:
Start: 10/01/19 End: 12/31/26 Due: 12/31/27

Study on the Prevention of Dermal Toxicity Caused by Regorafenib by Traditional Chinese Medicine TDX105

Phase: N/A Priority: Normal
NCT ID: NCT05289726 Org: User:
Start: 04/18/22 End: 04/18/23 Due: 04/18/24

Tislelizumab Combined With Chemotherapy in First-line Treatment of AGC

Phase: N/A Priority: Normal
NCT ID: NCT06034964 Org: User:
Start: 11/01/20 End: 11/01/25 Due: 11/01/26

SBRT With DIBH for HCC After TACE and Lipiodol Marking

Phase: N/A Priority: Normal
NCT ID: NCT05021250 Org: User:
Start: 07/21/21 End: 04/30/24 Due: 04/30/25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

Phase: N/A Priority: Normal
NCT ID: NCT04389073 Org: User:
Start: 04/01/20 End: 12/31/23 Due: 12/31/24

Durvalumab Combined With S-1 as Adjuvant Therapy of Resectable BTC

Phase: N/A Priority: Normal
NCT ID: NCT06490107 Org: User:
Start: 05/24/24 End: 12/30/27 Due: 12/30/28

Applications of Fluorescence Imaging Guided Lymph Node Dissection and Fluorescence Angiography of Inferior Mesenteric Artery Assisted Left Colic Artery Preservation

Phase: N/A Priority: Normal
NCT ID: NCT06033794 Org: User:
Start: 05/01/23 End: 05/01/24 Due: 05/01/25

Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04213937 Org: User:
Start: 01/31/20 End: 01/31/22 Due: 01/31/23

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04543695 Org: User:
Start: 08/15/20 End: 06/01/25 Due: 06/01/26

Research on the Combined-Modality Treatment Model of Bladder Preservation in Muscular Invasive Bladder Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02861196 Org: User:
Start: 09/30/15 End: 09/30/18 Due: 09/30/19